发明申请
WO2012072824A1 PHARMACEUTICAL COMPOSITIONS, DOSAGE FORMS AND NEW FORMS OF THE COMPOUND OF FORMULA (I), AND METHODS OF USE THEREOF
审中-公开
基本信息:
- 专利标题: PHARMACEUTICAL COMPOSITIONS, DOSAGE FORMS AND NEW FORMS OF THE COMPOUND OF FORMULA (I), AND METHODS OF USE THEREOF
- 专利标题(中):药物组合物,剂型和式(I)化合物的新形式及其使用方法
- 申请号:PCT/EP2011/071821 申请日:2011-12-05
- 公开(公告)号:WO2012072824A1 公开(公告)日:2012-06-07
- 发明人: MEIER, Ulrich , BIERI, Nicole , BECKER, Dieter , TAILLEMITE, Julien , FILLIOT, Marie-Pierre , MEISTER, Tanja
- 申请人: NOVARTIS AG , MEIER, Ulrich , BIERI, Nicole , BECKER, Dieter , TAILLEMITE, Julien , FILLIOT, Marie-Pierre , MEISTER, Tanja
- 申请人地址: Lichtstrasse 35 CH-4056 Basel CH
- 专利权人: NOVARTIS AG,MEIER, Ulrich,BIERI, Nicole,BECKER, Dieter,TAILLEMITE, Julien,FILLIOT, Marie-Pierre,MEISTER, Tanja
- 当前专利权人: NOVARTIS AG,MEIER, Ulrich,BIERI, Nicole,BECKER, Dieter,TAILLEMITE, Julien,FILLIOT, Marie-Pierre,MEISTER, Tanja
- 当前专利权人地址: Lichtstrasse 35 CH-4056 Basel CH
- 代理机构: WESTBERG, Suzanne
- 优先权: US61/419,567 20101203
- 主分类号: C07D409/12
- IPC分类号: C07D409/12 ; A61K31/517 ; A61P7/02
摘要:
The present invention relates to a novel crystalline anhydrous form of [(5-chlorothiophene-2- ylsulfonylcarbamoyl)-(4-(6-fluoro-7-(methylamino)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)- yl)phenyl)amide, potassium salt, and its use in the treatment or prevention of a condition or a disorder with platelet ADP receptor inhibition, in particular, P2Y 12 inhibition, in animals, particularly humans. It also relates processes for making such a novel crystalline form. The present invention also relates to a solid, oral formulation of this novel crystalline form, its preparation and use thereof.
摘要(中):
本发明涉及[(5-氯噻吩-2-基磺酰基氨基甲酰基) - (4-(6-氟-7-(甲基氨基)-2,4-二氧代-1,2-二氢喹唑啉-3( 4H) - 基)苯基)酰胺钾盐,以及其在动物,特别是人中治疗或预防血小板ADP受体抑制,特别是P2Y12抑制的病症或病症的用途。 它还涉及制备这种新型结晶形式的方法。 本发明还涉及这种新型结晶形式的固体,口服制剂及其制备和用途。
IPC结构图谱:
C | 化学;冶金 |
--C07 | 有机化学 |
----C07D | 杂环化合物 |
------C07D409/00 | 杂环化合物,含两个或更多个杂环,至少有1个环有硫原子作为仅有的杂环原子 |
--------C07D409/02 | .含有两个杂环 |
----------C07D409/12 | ..被含有杂原子的链作为键链连接的 |